Regis Corporation (NYSE:RGS) – Why I Remain Optimistic On Its Turnaround

Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.

Haw Par Group (SGX:H02) – A Simple Analysis II

I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.

A valuable read for investors looking to improve their decision-making skills in the stock market.

Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.

We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.

VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.

SOTP valuation shows Boustead's share price is undervalued. However, there may be a lack of near term catalyst for a rerate of share price.

uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.

Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.

We look at 5 intriguing earnings report I found during this earnings season